Assessment of medication self-administration using artificial intelligence

Nat Med. 2021 Apr;27(4):727-735. doi: 10.1038/s41591-021-01273-1. Epub 2021 Mar 18.

Abstract

Errors in medication self-administration (MSA) lead to poor treatment adherence, increased hospitalizations and higher healthcare costs. These errors are particularly common when medication delivery involves devices such as inhalers or insulin pens. We present a contactless and unobtrusive artificial intelligence (AI) framework that can detect and monitor MSA errors by analyzing the wireless signals in the patient's home, without the need for physical contact. The system was developed by observing self-administration conducted by volunteers and evaluated by comparing its prediction with human annotations. Findings from this study demonstrate that our approach can automatically detect when patients use their inhalers (area under the curve (AUC) = 0.992) or insulin pens (AUC = 0.967), and assess whether patients follow the appropriate steps for using these devices (AUC = 0.952). The work shows the potential of leveraging AI-based solutions to improve medication safety with minimal overhead for patients and health professionals.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Artificial Intelligence*
  • Humans
  • Insulin Infusion Systems
  • Middle Aged
  • Nebulizers and Vaporizers
  • Pharmaceutical Preparations / administration & dosage*
  • ROC Curve
  • Self Administration*
  • Wireless Technology
  • Young Adult

Substances

  • Pharmaceutical Preparations